144 results
Page 2 of 8
8-K
EX-99.1
v9pbed6biafeed
1 Sep 23
Kiora Pharmaceuticals Adjourns Special Meeting of Stockholders to September 27
7:00am
8-K
EX-99.1
tkgljpfn83 xqvu
8 Aug 23
Kiora Pharmaceuticals Announces Q2 2023 Earnings and Business Update, Highlighting Pipeline Updates and Clinical Development Progress
7:14am
8-K
EX-99.1
0dweur2zs6c
1 Aug 23
Biotech Leader Carmine Stengone Joins Kiora Pharmaceuticals' Board of Directors
7:00am
8-K
EX-99.1
csqgk
15 Jun 23
Kiora Pharmaceuticals and Sentrx Animal Care Amend Existing Manufacturing Licensing Agreement for KIO-201
4:59pm
8-K
EX-1.1
yf1apvaw
6 Jun 23
Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering
4:52pm
8-K
EX-99.1
gmhhn ujpuhmaq77oaus
6 Jun 23
Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering
4:52pm
8-K
EX-3.1
3uqo27
6 Jun 23
Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering
4:52pm
8-K
EX-99.2
mtb qfpkp
6 Jun 23
Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering
4:52pm
424B1
r6ajrwh7yk 7x
2 Jun 23
Prospectus with pricing info
5:08pm
FWP
ox9vtfpg nswh
15 May 23
Free writing prospectus
5:18pm
8-K
EX-99.1
ni8074f8
9 May 23
Kiora Pharmaceuticals Reports First Quarter Results; Positive Clinical Data Driving Significant Progress Advancing Pipeline of Eye Disease Treatments
7:02am